Biofrontera (BFRI) Payables (2020 - 2025)

Biofrontera's Payables history runs 6 years deep, the most recent figure standing at $4.8 million for Q4 2025.

• On a quarterly basis, Payables rose 159.21% year-over-year to $4.8 million in Q4 2025; TTM through Dec 2025 was $4.8 million, a 159.21% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 159.21% from the prior year.
• Payables rose to $4.8 million in Q4 2025 per BFRI's latest filing, from $2.1 million in the prior quarter.
• Across five years, Payables topped out at $7.2 million in Q4 2023 and bottomed at $200000.0 in Q3 2023.
• The 5-year median for Payables is $2.1 million (2025), against an average of $2.4 million.
• Across the five-year window, Payables sank 95.51% in 2023 and jumped 977.78% in 2025, its largest moves.
• Year by year, Payables stood at $940000.0 in 2021, then surged by 179.15% to $2.6 million in 2022, then soared by 174.85% to $7.2 million in 2023, then sank by 74.27% to $1.9 million in 2024, then surged by 159.21% to $4.8 million in 2025.
• Per Business Quant, the three latest BFRI Payables figures stand at $4.8 million (Q4 2025), $2.1 million (Q3 2025), and $4.3 million (Q2 2025).